Announcements Trials
Browse Landscape

Status

Completed 14Unknown 7Recruiting 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Breast Neoplasms 119Neoplasms 100Lung Neoplasms 66Colorectal Neoplasms 62Carcinoma, Hepatocellular 56Carcinoma, Non-Small-Cell Lung 53Prostatic Neoplasms 48Uterine Cervical Neoplasms 36Pancreatic Neoplasms 36Stomach Neoplasms 29Ovarian Neoplasms 28Disease 28Rectal Neoplasms 27Multiple Myeloma 25Leukemia, Myeloid, Acute 21Head and Neck Neoplasms 21Esophageal Neoplasms 21Endometrial Neoplasms 21Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Colonic Neoplasms 18Neoplasm Metastasis 17Glioma 17Glioblastoma 17Melanoma 15Lymphoma 15Cholangiocarcinoma 14Urinary Bladder Neoplasms 13Neoplasm, Residual 13Liver Neoplasms 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Intestinal Diseases × Clear all
NCT04893876 2022-08-18

The OPERa Study: Evaluating QoL After Rectal Cancer Surgery

Jewish General Hospital

Not yet recruiting
1,200 enrolled
GastrointestinalOther

Intestinal Diseases, Rectal Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡